Elisa Chiadini

1.1k total citations
28 papers, 800 citations indexed

About

Elisa Chiadini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Elisa Chiadini has authored 28 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Elisa Chiadini's work include Lung Cancer Treatments and Mutations (17 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (11 papers). Elisa Chiadini is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (11 papers). Elisa Chiadini collaborates with scholars based in Italy and Tunisia. Elisa Chiadini's co-authors include Paola Ulivi, Dino Amadori, Laura Capelli, Daniele Calistri, Wainer Zoli, Angelo Delmonte, Giovanni Luca Frassineti, Alessandro Passardi, Lucio Crinò and Angela Ragazzini and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Elisa Chiadini

28 papers receiving 793 citations

Peers

Elisa Chiadini

ONCOL

PRM

PFM

Federica Biello Italy

Maise Al Bakir United Kingdom

Rilan Bai China

Jinpeng Shi China

Naixin Liang China

Clarinda Chua Singapore

Baolan Li China

Soma Ghosh United States

F. De Vita Italy

Federica Biello Italy

Elisa Chiadini

634 ×1.3

ONCOL

418 ×0.9

PRM

292 ×0.9

267 ×1.2

65 ×0.6

PFM

Citations per year, relative to Elisa Chiadini Elisa Chiadini (= 1×) peers Federica Biello

Countries citing papers authored by Elisa Chiadini

Since Specialization

Citations

This map shows the geographic impact of Elisa Chiadini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Chiadini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Chiadini more than expected).

Fields of papers citing papers by Elisa Chiadini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Chiadini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Chiadini. The network helps show where Elisa Chiadini may publish in the future.

Co-authorship network of co-authors of Elisa Chiadini

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Chiadini. A scholar is included among the top collaborators of Elisa Chiadini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Chiadini. Elisa Chiadini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matteucci, Laura, Ilario Giovanni Rapposelli, Daniele Calistri, et al.. (2024). Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience. International Journal of Molecular Sciences. 25(20). 11071–11071. 2 indexed citations

Ambrosini‐Spaltro, Andrea, Claudia Rengucci, Laura Capelli, et al.. (2023). Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation. Current Oncology. 30(11). 10019–10032. 2 indexed citations

Verlicchi, Alberto, Matteo Canale, Elisa Chiadini, et al.. (2023). The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer. Life. 13(9). 1915–1915. 1 indexed citations

Liverani, Chiara, Chiara Spadazzi, Toni Ibrahim, et al.. (2023). HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors. Frontiers in Endocrinology. 13. 1045038–1045038. 3 indexed citations

Ambrosini‐Spaltro, Andrea, Anna Farnedi, Daniele Calistri, et al.. (2022). The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies’ integration. Human Pathology. 123. 20–30. 6 indexed citations

Farolfi, Alberto, Amelia Altavilla, Luca Morandi, et al.. (2022). Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice. Frontiers in Oncology. 12. 859510–859510. 6 indexed citations

Ulivi, Paola, Alessandro Passardi, Giorgia Marisi, et al.. (2021). Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences. Frontiers in Pharmacology. 12. 745701–745701. 3 indexed citations

Capelli, Laura, Elisa Chiadini, Matteo Canale, et al.. (2019). Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma. Cells. 8(6). 514–514. 14 indexed citations

Chiadini, Elisa, Matteo Canale, Angelo Delmonte, et al.. (2018). Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR). Journal of Thoracic Disease. 10(8). 4858–4864. 2 indexed citations

10.

Ulivi, Paola, Emanuela Scarpi, Elisa Chiadini, et al.. (2017). Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy. International Journal of Molecular Sciences. 18(6). 1240–1240. 39 indexed citations

11.

Canale, Matteo, Elisabetta Petracci, Angelo Delmonte, et al.. (2016). Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors. Clinical Cancer Research. 23(9). 2195–2202. 196 indexed citations

12.

Casadei‐Gardini, Andrea, Elisa Chiadini, Luca Faloppi, et al.. (2016). Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC Cancer. 16(1). 429–429. 31 indexed citations

13.

Ulivi, Paola, Matteo Canale, Elisabetta Petracci, et al.. (2016). Role of TP53 mutations in predicting response to TKI treatment in EGFR-mutated NSCLC patients.. Journal of Clinical Oncology. 34(15_suppl). 9052–9052. 4 indexed citations

14.

Ravaioli, Sara, Maria Maddalena Tumedei, Andrea Amadori, et al.. (2016). Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization. Journal of Lower Genital Tract Disease. 21(1). 42–46. 5 indexed citations

15.

Ulivi, Paola, Elisa Chiadini, Claudio Dazzi, et al.. (2015). Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy. Clinical Lung Cancer. 17(5). 384–390. 75 indexed citations

16.

Chiadini, Elisa, Emanuela Scarpi, Alessandro Passardi, et al.. (2015). EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab. Oncology Letters. 9(3). 1432–1438. 3 indexed citations

17.

Fabbri, Francesco�, Silvia Carloni, Wainer Zoli, et al.. (2013). Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Letters. 335(1). 225–231. 183 indexed citations

18.

Ulivi, Paola, Wainer Zoli, Laura Capelli, et al.. (2013). Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation. Molecular and Clinical Oncology. 1(4). 575–581. 41 indexed citations

19.

Ulivi, Paola, Laura Capelli, Martina Valgiusti, et al.. (2012). Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study. Journal of Translational Medicine. 10(1). 87–87. 36 indexed citations

20.

Ulivi, Paola, Chiara Arienti, Wainer Zoli, et al.. (2010). In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells. Current Cancer Drug Targets. 10(6). 600–610. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact